info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Global Autoinjectors Market will be Worth 238.7 Billion US Dollars by 2030.

Global Autoinjectors Market will be Worth 238.7 Billion US Dollars by 2030.


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The autoinjectors market are segmented into by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis and Other Therapies), Type (Reusable Autoinjectors and Disposable Autoinjectors), Route of Administration (Intramuscular, Subcutaneous), End-User (Hospitals & Clinics, Home Care Settings and Ambulatory Care Settings) and Region. Forty-six billion US dollars is the estimated market size of global autoinjectors during 2020. According to the studies, it is estimated to become 238.7 billion US dollars by 2030, with an increasing CAGR value of 17.9% from 2020 to 2030.   

To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/autoinjectors-market

 

Critical Drivers accounting for the market growth:

The main key factors contributing to the growth of the global autoinjectors market are anaphylaxis, targeted therapies, and regulatory approvals. In addition, advancements in technology and an increase in chronic diseases requiring frequent consultation are the key factors that accounted for the increase in market growth.

 

By type of therapy used, "Rheumatoid Arthritis" held the maximum share during 2020

The autoinjectors market is further segmented into anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and a few other categories such as migraine treatment, progesterone therapy, and cardiovascular diseases based on the therapy. Many cases of Rheumatoid Arthritis are the reason behind its significant growth of the market. In the United States, approximately 43.7 million adults, which constitute 22.7% of the total population, are affected by arthritis, thus increasing the demand for autoinjectors.

 

By type of autoinjectors used, "Disposable autoinjectors" held the maximum share during 2020

In contrast, disposable autoinjectors constituted for maximum market share during 2020 due to an increase in anaphylaxis and rheumatoid arthritis cases. Also, ease of use, simple administration, and rapid action of autoinjectors made it popular among patients and constituted for its growth.

 

By route of administration, "subcutaneous" held the maximum share during 2020

The autoinjectors market is further segmented into Intramuscular and Subcutaneous based on the route of administration. Usually, autoinjectors based on the route of administration, such as intramuscular and subcutaneous, are used for diseases such as anemia, multiple sclerosis, migraine, anaphylaxis, rheumatoid arthritis, diabetes, and cancer. Therefore, it is estimated that the subcutaneous segment will see rapid growth with a growing CAGR throughout the forecast period. 

 

By end-user, "home care setting" held the maximum share during 2020

The autoinjectors market is further segmented into hospitals and clinics, home care settings, and ambulatory care settings. Home care settings had a significant market share during the forecasted period with a steady CAGR. The need for an affordable drug delivery system accounted for the rapid growth of home care setting segments.

 

By region, "North America" held the maximum share during 2020

The autoinjectors market is further segmented into North America, Asia Pacific, Europe, Latin America, Africa, and the Middle East. North America currently has a significant market share; increased diabetes and Rheumatoid Arthritis cases constituted the growth of this segment. The current market share is 41% approximately, while it is estimated to be growing at a CAGR of 19-22%.

 

Recent Developments in Autoinjectors Market Globally

  • In Aug 2020, an agreement was signed between Antares Pharma which is in the US, and Global Medical Supplier, present in Dubai. By the agreement signed, Lunatus will obtain and submit regulatory approval in Saudi Arabia and UAE while promoting and distributing XYOSTED in the market and supplying packaged products will be taken care of by Antares.
  • In March 2020, the acquisition between SHL Medical situated in Switzerland and Weibel CDS in Switzerland took place. The primary output that was expected from this acquisition is to intensify SHL Medical's strength in manufacturing human-centered designs for advanced drug admirations.
  • In January 2020, a massive amount of 470 million US dollars was invested by Eli Lilly, which created new jobs for almost 460 people in Durham, NC. Due to this enormous expansion, North Carolina's research triangle witnessed a new state of the art.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved